Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/01/2026 | CALL | $1,250.00 | 1,070 | +982 | +1,115.91% |
| 05/01/2026 | CALL | $1,400.00 | 688 | +404 | +142.25% |
| 04/24/2026 | CALL | $950.00 | 1,462 | +354 | +31.95% |
| 05/08/2026 | PUT | $890.00 | 426 | +332 | +353.19% |
| 06/18/2026 | PUT | $400.00 | 414 | +263 | +174.17% |
| 04/24/2026 | PUT | $830.00 | 982 | +252 | +34.52% |
| 05/15/2026 | CALL | $1,100.00 | 676 | -53 | -7.27% |
| 07/17/2026 | PUT | $840.00 | 674 | -58 | -7.92% |
| 06/18/2026 | CALL | $1,000.00 | 1,477 | -60 | -3.90% |
| 05/15/2026 | PUT | $960.00 | 193 | -100 | -34.13% |
| 05/15/2026 | PUT | $1,100.00 | 48 | -100 | -67.57% |
| 04/24/2026 | PUT | $880.00 | 602 | -162 | -21.20% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
Should You Add a Healthcare Stock to Your Portfolio This Month? And Should It Be Eli Lilly (LLY)?
04/25 07:05 pm
The Motley Fool
Read moreIs This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom?
04/25 01:05 pm
The Motley Fool
Read moreWhy Eli Lilly Stock Flopped on Friday
04/24 06:30 pm
The Motley Fool
Read moreDeal Dispatch: QXO Nabs TopBuild For $17 Million, Voya Financial Urged To Evaluate Strategic Options, Pat McGrath Exits Chapter 11
04/24 02:27 pm
Benzinga
Read moreRadiopharmaceuticals Market Size to Exceed USD 15.21 Billion By 2035 Rising Cancer Cases Boost the Market Demand
04/24 09:57 am
GlobeNewswire Inc.
Read moreOmics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
04/24 04:59 am
GlobeNewswire Inc.
Read moreHims & Hers Positions Itself As Supply Anchor In Hormone Therapy Crunch
04/23 12:19 pm
Benzinga
Read moreKailera Therapeutics' Strong IPO Validates "NewCo" Strategy
04/23 12:08 pm
Benzinga
Read moreIs Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap?
04/23 09:30 am
The Motley Fool
Read moreForget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
04/23 05:30 am
The Motley Fool
Read more3 Healthcare Stocks With the Most Durable Competitive Moats
04/23 04:05 am
The Motley Fool
Read moreLarge Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges
04/22 02:20 pm
Benzinga
Read moreWhy Did Eli Lilly Stock Drop Today?
04/21 10:35 am
The Motley Fool
Read moreA Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly
04/21 07:30 am
The Motley Fool
Read moreWhy Legend Biotech Stock Crushed the Market on Monday
04/20 06:16 pm
The Motley Fool
Read moreWill Eli Lilly's New GLP-1 Pill Get the Stock Get Back to a $1 Trillion Valuation?
04/20 10:15 am
The Motley Fool
Read moreThis Drug Stock Has Crushed the S&P 500 Over the Last Decade
04/18 05:15 pm
The Motley Fool
Read moreDeal Dispatch: Amazon Buys Globalstar, Instacart Grabs Instaleap, QVC Announces Bankruptcy
04/17 02:33 pm
Benzinga
Read moreKailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race
04/17 01:23 pm
Benzinga
Read moreNovo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake
04/17 12:04 pm
Benzinga
Read moreChina Diabetes Devices Market Forecast and Company Analysis Report 2026-2034 Featuring Roche, Abbott Laboratories, Novo Nordisk, BD, Medtronic, Eli Lilly, and Sanofi
04/17 12:00 pm
GlobeNewswire Inc.
Read moreIs Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?
04/17 05:10 am
The Motley Fool
Read moreNon-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight
04/16 01:00 pm
GlobeNewswire Inc.
Read moreEli Lilly Partner MeiraGTx Regains Rights For Genetic Eye Disease Drug From Johnson & Johnson
04/16 10:16 am
Benzinga
Read moreIs This $6.3 Billion Deal a Game Changer for Eli Lilly?
04/16 09:30 am
The Motley Fool
Read moreEli Lilly's New Oral Weight Loss Drug Clears Cardiovascular Bar
04/16 08:39 am
Benzinga
Read morePrediction: This 1 Thing Could Cement Eli Lilly's Leadership in the Billion-Dollar Weight Loss Drug Market
04/16 04:08 am
The Motley Fool
Read moreThe $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust
04/15 01:26 pm
The Motley Fool
Read moreGoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market
04/15 01:25 pm
Benzinga
Read moreEli Lilly's Jaypirca Builds Case With Fourth Positive Phase 3 Trial In Blood Cancer Patients
04/13 09:29 am
Benzinga
Read moreDementia Market Insight, Epidemiology, and Forecasts, 2022-2025 & 2026-2034
04/13 04:59 am
GlobeNewswire Inc.
Read moreHere's Why Buying This Vanguard Index Fund Today Could Be the Best Financial Decision You Ever Make
04/10 03:15 pm
The Motley Fool
Read moreAtopic Dermatitis (7MM) Drug Market Forecast and Analysis Report 2023-2033: Opportunities Remain for the Treatment of AD, Novel Systemic Therapies Dominate the Late-stage Pipeline
04/10 04:52 am
GlobeNewswire Inc.
Read moreAtopic Dermatitis 68-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033
04/10 04:46 am
GlobeNewswire Inc.
Read moreCrohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032
04/10 04:43 am
GlobeNewswire Inc.
Read moreFoghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
04/09 07:00 am
GlobeNewswire Inc.
Read moreEli Lilly Faces Pressure In India As Cheaper GLP-1 Rivals Dent Mounjaro Sales
04/09 06:44 am
Benzinga
Read moreTrogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model
04/09 02:00 am
GlobeNewswire Inc.
Read moreNxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
04/08 07:34 pm
GlobeNewswire Inc.
Read moreProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
04/08 04:00 pm
GlobeNewswire Inc.
Read moreLooks Like M&A Week in 3 Different Sectors
04/08 12:02 pm
The Motley Fool
Read moreIncyclix Bio Raises Additional $5 Million in Series B Financing to Advance Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
04/08 07:00 am
GlobeNewswire Inc.
Read moreAC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
04/07 07:00 am
GlobeNewswire Inc.
Read moreTrump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime
04/06 01:20 pm
Investing.com
Read moreEli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight
04/04 01:32 pm
The Motley Fool
Read moreWhy Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market
04/03 05:02 pm
The Motley Fool
Read moreWhere Will Viking Therapeutics Stock Be in 10 Years?
04/03 03:26 pm
The Motley Fool
Read moreDeal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy
04/03 10:35 am
Benzinga
Read moreDow, S&P 500, Nasdaq: From Morning Meltdown to Midday "Meh"
04/02 02:25 pm
The Motley Fool
Read moreLilly’s Next Empire: A $10 Billion Bet on AI and Neuroscience
04/02 01:51 pm
Investing.com
Read more